Dr Reddy’s Laboratories has announced that its wholly-owned subsidiary, Aurigene Oncology Limited (formerly Aurigene Discovery Technologies Limited), has invested ₹649,99,99,520 (approximately ₹6,500 million) in Aurigene Pharmaceutical Services Limited (APSL). Aurigene Pharmaceutical Services Limited issued 11,60,71,420 equity shares to AOL on May 30, 2024, at ₹10 each, with a premium of ₹46 per share. Aurigene Pharmaceutical …